Skip to content

efficacy of Medhya Rasayan in Senile Dementia.

Study the efficacy of Medhya Rasayan in Senile Dementia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027556
Enrollment
100
Registered
2020-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G301- Alzheimers disease with late onset

Interventions

Intervention1: 1 Medhya Rasayan: It will be the interventional drug.combination of Madukparni, Guduchi, Shankhapushoi made in form of Ghruta and will be given to Group A patients selected by randomiz

Sponsors

Pooja kombe
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Case definition – 1. Cardinal features of mild cognitive Dementia like some memory troubles and trouble finding words, but they solve everyday problems and handle their own life affairs well. 2. MMSC scoring 18 -23 (Mild cognitive impairment)

Exclusion criteria

Exclusion criteria: 1. Patients with evidence of delirium, confusion or other disturbances of consciousness, Parkinson’s disease, stroke, intracranial hemorrhage, brain tumors, history of alcoholism or drug dependence, use of any psychotropic drug, diabetes mellitus, etc 2. Patients with loss of physical capabilities, such as walking, sitting, and holding one’s head up and eventually, ability to swallow, to control the bladder and bowel function. 3. Patients with loss of ability to communicate.

Design outcomes

Primary

MeasureTime frame
Medhya Rasayan is effective in Senile Dementia. Efficacy will be assesed with mini mental scale examination under the heads orientation, registration, attention - calculation, recall, languageTimepoint: At the end of study after 3 months administration of medhya rasayan reassessment will be done to see the results

Secondary

MeasureTime frame
Medhya Rasayan may or may not be effective in Senile Dementia. Efficacy will be assesed with mini mental scale examination under the heads orientation, registration, attention - calculation, recall, languageTimepoint: After completing the three months of administration of medhya rasayan, 1 month gap will be given without giving medhya rasayan and after gap 4th assessment will be done on for how longer effect of medhya rasayan last longer

Countries

India

Contacts

Public ContactPooja Kombe

MGACH Wardha

vkuchewar@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026